» Authors » O Glehen

O Glehen

Explore the profile of O Glehen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 114
Citations 2925
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Benzerdjeb N, Dartigues P, Kepenekian V, Damiola F, Sequeiros R, Galateau-Salle F, et al.
ESMO Open . 2024 Jul; 9(8):103644. PMID: 39059063
Background: Mesothelioma is a rare and aggressive malignant neoplasm arising from mesothelial cells, which occasionally manifests recurrent fusions. EWSR1/FUS-CREB, YY1, MAP3K8, NR4A3, and ALK-rearranged proliferations have been reported in limited...
2.
Aubert M, Mege D, Goere D, Ezzedine W, Pocard M, Quenet F, et al.
Eur J Surg Oncol . 2024 Jul; 50(9):108507. PMID: 38954880
Background: Obesity is a public health concern with an increasing occurrence worldwide. Literature regarding impact of obesity on results after management of peritoneal carcinomatosis is poor. Our aim was to...
3.
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, et al.
Eur J Surg Oncol . 2023 Aug; 49(10):107001. PMID: 37579618
Methods: An international registry was designed through a networking database (REDCAP®). All centers performing L-CRS + HIPEC were invited through PSOGI to submit data on their cases. Variables such as...
4.
Pocard M, So J, Huchon C, Robella M, Chavatte-Palmer P, Eveno C, et al.
J Visc Surg . 2022 Oct; 160(1):52-54. PMID: 36270954
Pressurized intraperitoneal aerosol chemotherapy, named PIPAC, is now used in many centers around the world and as an intraperitoneal drug delivery system for treatment of peritoneal carcinomatosis. Recently, many of...
5.
Bonnot P, Lintis A, Mercier F, Benzerdjeb N, Passot G, Pocard M, et al.
Br J Surg . 2021 Sep; 108(10):1225-1235. PMID: 34498666
Background: The incidence of gastric poorly cohesive carcinoma (PCC) is increasing. The prognosis for patients with peritoneal metastases remains poor and the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal...
6.
Vacheron C, Lambert A, Fauvernier M, Vassal O, Wallet F, Bakrin N, et al.
Br J Surg . 2021 Jun; 108(9):e297-e298. PMID: 34136898
No abstract available.
7.
Arquilliere J, Glehen O, Passot G
J Visc Surg . 2021 Jan; 158(3):258-264. PMID: 33487563
No abstract available.
8.
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Esquivel J, Van der Speeten K, et al.
Eur J Surg Oncol . 2020 Dec; 47(6):1420-1426. PMID: 33298341
Introduction: A laparoscopic approach for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (L-CRS+HIPEC) in highly selected patients has been reported in small cohorts with a demonstrable reduction in length of stay...
9.
10.
Bhatt A, Rousset P, Benzerdjeb N, Kammar P, Mehta S, Parikh L, et al.
Colorectal Dis . 2020 Sep; 22(12):2123-2132. PMID: 32940414
Aim: The peritoneal cancer index (PCI) is one of the strongest prognostic factors in patients undergoing cytoreductive surgery (CRS) for colorectal peritoneal metastases. Using pathological evaluation, however, the disease extent...